T2 Biosystems CS (TTOO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2013 | 12-2012 | 12-2006 | |
| Sales | 266 | 19 | 0 |
| Gross Profit | 266 | 19 | N/A |
| Operating Expenses | 19,958 | 14,672 | 0 |
| Operating Income | -19,692 | -14,653 | N/A |
| Interest Expense | 403 | 154 | 0 |
| Other Income | -515 | 352 | 0 |
| Pre-tax Income | -20,610 | -14,455 | 0 |
| Net Income Continuous | -20,610 | -14,455 | N/A |
| Net Income | $-20,610 | $-14,455 | $N/A |
| EPS Basic Total Ops | -98,600.00 | -69,300.00 | N/A |
| EPS Basic Continuous Ops | -73,841.22 | -53,080.31 | N/A |
| EPS Diluted Total Ops | -98,600.00 | -69,300.00 | N/A |
| EPS Diluted Continuous Ops | -73,841.22 | -53,080.31 | N/A |
| EBITDA(a) | $-19,108 | $-14,082 | $N/A |